Latest Cambridge News | Page 3

Honorary Doctorate awarded to Secretary General of OECD
Funding for Würzburg Biophysicist
Water quality boosted through Greening Our Communities projects
AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes
Truqap (capivasertib) plus Faslodex approved in the US for patients with advanced HR-positive breast cancer
New director for WEHI
Tender out for Cambridge Primary School redevelopment
Imfinzi plus chemotherapy approved in China as first immunotherapy regimen for patients with locally advanced or metastatic biliary tract cancer
Update on PACIFIC-2 Phase III trial of Imfinzi concurrently administered with platinum-based chemoradiotherapy in unresectable, Stage III non-small cell lung cancer
Fire is consuming more than ever of the world’s forests, threatening supplies of wood and paper
Sydney man accused of soliciting child abuse material
Collingwood’s biggest park officially opened
Police appeal to locate man missing from Fairfield West
The University of Manchester is proud to support National Productivity Week
Imfinzi plus bevacizumab met primary endpoint for progression-free survival in liver cancer eligible for embolisation in EMERALD-1 Phase III trial
Luminous ‘mother-of-pearl’ clouds explain why climate models miss so much Arctic and Antarctic warming
A 4-day week might not work in health care. But adapting this model could reduce burnout among staff
Zibotentan/dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria in ZENITH-CKD Phase IIb trial
ZORA real-world evidence demonstrates that Lokelma substantially increases cardiorenal patients’ chances of maintaining lifesaving RAASi therapy
AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions
New WA Government subsidy to attract English language teachers
Drink driver caught more than 4 times legal limit
Stolen car charges in Alexandra Hills, QLD
Rabbits as ‘starter pets’ for kids
Doctors are being sexually harassed at work. This needs to stop
Council delivers two new recreation spaces for Cambridge Gardens
Man and woman charged with drink driving offences in southern Tasmania
New pool, facilities upgrades highlights of Aquatics Strategy
Closure of Kilsyth Centenary Pool
US Food and Drug Administration accepts for review AstraZeneca’s Supplemental Biologics License Application for self-administration of FluMist Quadrivalent
New look Cambridge Primary School revealed
Walk your way to lower blood pressure
Soliris approved in China for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD)
Asha founder awarded honorary doctorate
Tagrisso plus chemotherapy granted Priority Review in the US for patients with EGFR-mutated advanced lung cancer
Quick call from member of public sees Cambridge man arrested
Arrests made after assault in Cambridge
AstraZeneca awards funding to eight innovative research projects from early-career scientists around the world in second R&D Postdoctoral Challenge
Legislation introduced to expand national park under Plan for Our Parks
Alexion data at 9th Joint ECTRIMS-ACTRIMS Meeting (MSMilan2023) showcase impact of C5 inhibition in NMOSD
Residue from household disinfectants may be leading to drug resistance in deadly bacteria
Deakin secures ARC Discovery Indigenous scheme funding
The University of Manchester joins landmark mission to trace Universe back to the Big Bang
IAG appoints William McDonnell as Chief Financial Officer
AstraZeneca research reveals unique associations between rare changes in genes and plasma proteins that could improve drug discovery with data from over…
Forxiga met primary endpoint in T2NOW Phase III trial, one of the largest paediatric type 2 diabetes studies performed to date
AstraZeneca settles Nexium and Prilosec product liability litigations
Listening to atoms moving at the nanoscale: study